Microbiome in Cancer Development and Treatment

Area of Science:

• Oncology
• Microbiology
• Immunology

Background:

• Cancer treatments negatively affect gut homeostasis, causing dysbiosis and complications like inflammation and bacterial translocation.
• Gut microbiome imbalance is linked to increased treatment-related toxicity.
• The microbiome influences tumor development and response to cancer therapies.

Purpose of the Study:

• To review the role of the microbiome in cancer development.
• To examine the impact of gut and tumor microbiomes on chemotherapy and immunotherapy efficacy.
• To discuss microbiota modulation strategies for cancer patient care.

Main Methods:

• Literature review of current research on the microbiome in oncology.
• Analysis of studies investigating the relationship between gut microbiota and treatment toxicity.
• Exploration of microbiota modulation techniques.

Main Results:

• Microbiome alterations negatively impact cancer treatment outcomes.
• Gut dysbiosis contributes to severe treatment complications and late effects.
• Microbiota modulation shows promise in improving treatment response and reducing toxicity.

Conclusions:

• Understanding the microbiome-host relationship is crucial for clinical integration.
• Microbiota modulation can enhance treatment efficacy and patient outcomes.
• Identifying microbial biomarkers may aid in diagnosis and prognosis.